Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.53B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$1.28B |
| 3 |
Microsoft
MSFT
|
+$1.27B |
| 4 |
Intercontinental Exchange
ICE
|
+$876M |
| 5 |
Parker-Hannifin
PH
|
+$753M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 2 |
Visa
V
|
+$890M |
| 3 |
Fortive
FTV
|
+$739M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$457M |
| 5 |
TSMC
TSM
|
+$392M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.21% |
| 2 | Technology | 17.8% |
| 3 | Industrials | 7.2% |
| 4 | Consumer Discretionary | 7% |
| 5 | Healthcare | 6.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TIGR
5951
UP Fintech Holding
TIGR
$833M
| $24K | ﹤0.01% |
3,700
+3,204
| +646% | +$22K |
|
|
AUGP
5952
PGIM US Large-Cap Buffer 12 ETF - August
AUGP
$25.2M
| $24K | ﹤0.01% |
+901
| New | +$24.4K |
|
|
TBCH
5953
Turtle Beach Corp
TBCH
$230M
| $24K | ﹤0.01% |
1,426
-565
| -28% | -$9.24K |
|
|
AIXI
5954
Xiao-I
AIXI
$815K
| $23K | ﹤0.01% |
+197
| New | +$22.3K |
|
5955
Compass Therapeutics
CMPX
$407M
| $23K | ﹤0.01% |
15,343
+4,192
| +38% | +$6.96K |
|
5956
Citi Trends
CTRN
$617M
| $23K | ﹤0.01% |
892
+191
| +27% | +$4.02K |
|
5957
1-800-Flowers.com
FLWS
$262M
| $23K | ﹤0.01% |
2,774
-74
| -3% | -$593 |
|
|
INZY
5958
DELISTED
Inozyme Pharma
INZY
| $23K | ﹤0.01% |
8,577
+3,053
| +55% | +$11.6K |
|
5959
James River Group Holdings
JRVR
$199M
| $23K | ﹤0.01% |
4,724
-923
| -16% | -$5.08K |
|
|
LGO
5960
Largo
LGO
$76.5M
| $23K | ﹤0.01% |
13,364
+2,463
| +23% | +$5.03K |
|
|
ONTF
5961
DELISTED
ON24
ONTF
| $23K | ﹤0.01% |
3,555
+916
| +35% | +$5.88K |
|
|
PPTA
5962
Perpetua Resources
PPTA
$3.1B
| $23K | ﹤0.01% |
2,190
-3,316
| -60% | -$34K |
|
5963
iShares MSCI Qatar ETF
QAT
$63.5M
| $23K | ﹤0.01% |
+1,277
| New | +$23.3K |
|
5964
Simplify US Equity PLUS Downside Convexity ETF
SPD
$107M
| $23K | ﹤0.01% |
700
-12
| -2% | -$409 |
|
|
TSVT
5965
DELISTED
2seventy bio
TSVT
| $23K | ﹤0.01% |
7,716
+3,143
| +69% | +$12.9K |
|
5966
Virax Biolabs
VRAX
$2.25M
| $23K | ﹤0.01% |
+416
| New | +$19.9K |
|
|
PBDE
5967
PGIM US Large-Cap Buffer 20 ETF - December
PBDE
$36.9M
| $23K | ﹤0.01% |
+889
| New | +$23.5K |
|
|
ARDT
5968
Ardent Health
ARDT
$1.57B
| $23K | ﹤0.01% |
1,351
-212
| -14% | -$3.67K |
|
|
NVRO
5969
DELISTED
NEVRO CORP.
NVRO
| $23K | ﹤0.01% |
6,279
+1,614
| +35% | +$7.45K |
|
5970
ProFrac Holding
ACDC
$936M
| $22K | ﹤0.01% |
2,799
+525
| +23% | +$3.77K |
|
5971
Anterix
ATEX
$1.74B
| $22K | ﹤0.01% |
734
-1,916
| -72% | -$63.7K |
|
|
CAN
5972
Canaan Creative
CAN
$159M
| $22K | ﹤0.01% |
10,824
| – | – |
|
|
EEX
5973
DELISTED
Emerald Holding
EEX
| $22K | ﹤0.01% |
4,542
+51
| +1% | +$234 |
|
5974
Pulmonx
LUNG
$98.4M
| $22K | ﹤0.01% |
3,240
-2,300
| -42% | -$15.1K |
|
|
RINC
5975
DELISTED
AXS Real Estate Income ETF
RINC
| $22K | ﹤0.01% |
987
| – | – |
|
Similar funds
Royal Bank of Canada's Q4 2024 Portfolio in Review
As of Q4 2024, Royal Bank of Canada held 7,459 positions worth $501B, up 2.2% from $490B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Royal Bank of Canada's Q4 2024 filing shows 484 new, 3,145 increased, 2,823 reduced and 402 closed positions. Its largest new stake was South Bow Corp: 18,412,117 shares worth $434M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.82B.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q4 2024 buy was South Bow Corp: 18,412,117 shares worth $434M.
- Royal Bank of Canada added most to NVIDIA in Q4 2024, an estimated $1.53B increase.
- Royal Bank of Canada's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.82B.
- Royal Bank of Canada fully exited CATALENT, INC. in Q4 2024, selling an estimated $43.7M.
- Royal Bank of Canada's ten largest holdings make up 20% of its $501B portfolio in Q4 2024.
- Royal Bank of Canada opened 484 new positions and closed 402 in Q4 2024.
- Royal Bank of Canada's portfolio value rose 2.2% quarter-over-quarter to $501B.
Based on Royal Bank of Canada's 13F filing for Q4 2024, filed 14 Feb 2025.